[Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer] (Q74334425)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

[Alternating chemotherapy and hyperfractionated accelerated radiotherapy in non-metastatic inflammatory breast cancer] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

inflammatory breast cancer

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

A Hasbini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Le Péchoux

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B Roche

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J P Pignol

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

L Zelek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B Abdulkarim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J M Guinebretière

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Tardivon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Spielmann

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J L Habrand

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

265-273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Adequate locoregional treatment for early breast cancer may prevent secondary dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Results of treating stage iii carcinoma of the breast by primary radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Inflammatory breast carcinoma treated by radical radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Prognostic factors in inflammatory breast cancer. Univariate and multivariate analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Inflammatory carcinoma of the breast: treatment results on 107 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Inflammatory breast cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Therapeutic strategies in inflammatory breast carcinoma based on prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Inflammatory symptoms in breast cancer. Correlations with growth rate, clinicopathologic variables, and evolution

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Multimodal treatment for inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

Combined Chemotherapy, Radiotherapy and Surgery in Inflammatory Breast Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2800%2980004-9

7 January 2021

10.1016/S1278-3218(00)80004-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10994390%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference